Alaunos Therapeutics, Inc.
TCRT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,261 | $8 | $2 | $3 |
| - Cash | $2 | $3 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5,259 | $5 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -50% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | -53,650% | -18,550% |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | -53,650% | -18,550% |
| EPS Diluted | -0.55 | -0.63 | -0.67 | -0.46 |
| % Growth | 12.7% | 6% | -45.7% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$1 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$1 |